Ralph Laufer

4.2k total citations
61 papers, 2.8k citations indexed

About

Ralph Laufer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Infectious Diseases. According to data from OpenAlex, Ralph Laufer has authored 61 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 13 papers in Infectious Diseases. Recurrent topics in Ralph Laufer's work include HIV/AIDS drug development and treatment (12 papers), Neuropeptides and Animal Physiology (8 papers) and Hepatitis C virus research (8 papers). Ralph Laufer is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), Neuropeptides and Animal Physiology (8 papers) and Hepatitis C virus research (8 papers). Ralph Laufer collaborates with scholars based in Italy, United States and Israel. Ralph Laufer's co-authors include Annalise Di Marco, Jean‐Pierre Changeux, Donald J. Marsh, Paul Burn, Gunther Hollopeter, Richard D. Palmiter, Keith A. Yagaloff, Dennis Huszar, Stewart L. Fisher and Gennaro Ciliberto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Ralph Laufer

60 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph Laufer Italy 27 1.1k 555 460 414 381 61 2.8k
Keld Fosgerau Denmark 18 2.1k 1.8× 185 0.3× 398 0.9× 59 0.1× 111 0.3× 33 3.6k
Laura A. Solt United States 36 1.8k 1.6× 1.5k 2.7× 457 1.0× 56 0.1× 122 0.3× 64 5.1k
Matthias Engel Germany 36 1.8k 1.6× 139 0.3× 253 0.6× 71 0.2× 175 0.5× 134 3.7k
Yasuyuki Ishii Japan 32 843 0.7× 402 0.7× 251 0.5× 48 0.1× 187 0.5× 90 2.5k
Kentaro Oh‐hashi Japan 25 990 0.9× 178 0.3× 347 0.8× 91 0.2× 96 0.3× 129 2.2k
Xiaorong Zhu United States 28 1.5k 1.3× 529 1.0× 473 1.0× 63 0.2× 363 1.0× 60 3.3k
Hans‐Gottfried Genieser Germany 32 2.9k 2.5× 153 0.3× 723 1.6× 84 0.2× 90 0.2× 82 4.3k
Michael D. Knierman United States 24 1.5k 1.3× 651 1.2× 449 1.0× 32 0.1× 456 1.2× 43 3.2k
Ronald D. Sekura United States 33 2.4k 2.1× 138 0.2× 782 1.7× 97 0.2× 131 0.3× 51 3.7k
Serge Picard Canada 33 1.3k 1.2× 97 0.2× 376 0.8× 105 0.3× 203 0.5× 63 3.2k

Countries citing papers authored by Ralph Laufer

Since Specialization
Citations

This map shows the geographic impact of Ralph Laufer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Laufer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Laufer more than expected).

Fields of papers citing papers by Ralph Laufer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Laufer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Laufer. The network helps show where Ralph Laufer may publish in the future.

Co-authorship network of co-authors of Ralph Laufer

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Laufer. A scholar is included among the top collaborators of Ralph Laufer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Laufer. Ralph Laufer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bugiani, Marianna, Truus E. M. Abbink, Arthur W. D. Edridge, et al.. (2023). Focal lesions following intracerebral gene therapy for mucopolysaccharidosis IIIA. Annals of Clinical and Translational Neurology. 10(6). 904–917. 6 indexed citations
2.
Pokorná, Šárka, Olga Khersonsky, Rosalie Lipsh‐Sokolik, et al.. (2023). Design of a stable human acid‐β‐glucosidase: towards improved Gaucher disease therapy and mutation classification. FEBS Journal. 290(13). 3383–3399. 8 indexed citations
3.
Tabet, Ricardos, Fabrice Riet, Doulaye Dembélé, et al.. (2022). AAV‐delivered diacylglycerol kinase DGKk achieves long‐term rescue of fragile X syndrome mouse model. EMBO Molecular Medicine. 14(5). e14649–e14649. 12 indexed citations
4.
Hocquemiller, Michaël, Kim M. Hemsley, Daniel Neumann, et al.. (2019). AAVrh10 Vector Corrects Disease Pathology in MPS IIIA Mice and Achieves Widespread Distribution of SGSH in Large Animal Brains. Molecular Therapy — Methods & Clinical Development. 17. 174–187. 25 indexed citations
5.
Grossman, Iris, Volker Knappertz, Daphna Laifenfeld, et al.. (2016). Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research. Progress in Neurobiology. 152. 114–130. 20 indexed citations
6.
Pacini, Barbara, Renzo Bazzo, Uwe Koch, et al.. (2009). Cyclic phosphoramidates as prodrugs of 2′-C-methylcytidine. European Journal of Medicinal Chemistry. 44(9). 3765–3770. 25 indexed citations
7.
Donghi, Monica, Cristina Gardelli, Annalise Di Marco, et al.. (2009). Synthesis and evaluation of novel phosphoramidate prodrugs of 2′-methyl cytidine as inhibitors of hepatitis c virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 19(5). 1392–1395. 28 indexed citations
8.
Scarpelli, Rita, Annalise Di Marco, Federica Ferrigno, et al.. (2008). Studies of the metabolic stability in cells of 5-(trifluoroacetyl)thiophene-2-carboxamides and identification of more stable class II histone deacetylase (HDAC) inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(23). 6078–6082. 17 indexed citations
9.
Marco, Annalise Di, Antonella Cellucci, Ashok Chaudhary, Massimiliano Fonsi, & Ralph Laufer. (2007). High-Throughput Radiometric CYP2C19 Inhibition Assay Using Tritiated (S)-Mephenytoin. Drug Metabolism and Disposition. 35(10). 1737–1743. 11 indexed citations
10.
Marco, Annalise Di, et al.. (2005). DETERMINATION OF DRUG GLUCURONIDATION AND UDP-GLUCURONOSYLTRANSFERASE SELECTIVITY USING A 96-WELL RADIOMETRIC ASSAY. Drug Metabolism and Disposition. 33(6). 812–819. 42 indexed citations
11.
Malancona, Savina, Stefania Colarusso, Jesus M. Ontoria, et al.. (2004). SAR and pharmacokinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3/NS4A serine protease. Bioorganic & Medicinal Chemistry Letters. 14(17). 4575–4579. 20 indexed citations
12.
Lee, Nancy, et al.. (2004). Penetrating brain injury leads to activation of ciliary neurotrophic factor receptors. Neuroscience Letters. 374(3). 161–165. 4 indexed citations
13.
Lamartina, Stefania, Giuseppe Roscilli, Danilo R. Casimiro, et al.. (2003). Construction of an rtTA2s-m2/ttskid-Based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and Non-Human primates. Molecular Therapy. 7(2). 271–280. 63 indexed citations
14.
Marco, Annalise Di, Anna Demartis, Isabelle Gloaguen, et al.. (2000). Leptin receptor‐mediated regulation of cholinergic neurotransmitter phenotype in cells of central nervous system origin. European Journal of Biochemistry. 267(10). 2939–2944. 10 indexed citations
15.
Meazza, Cristina, Annalise Di Marco, Paolo Fruscella, et al.. (1997). Centrally Mediated Inhibition of Local Inflammation by Ciliary Neurotrophic Factor. NeuroImmunoModulation. 4(5-6). 271–276. 13 indexed citations
16.
Graziani, Rita, et al.. (1995). In vitroBinding of Ciliary Neurotrophic Factor to its Receptors: Evidence for the Formation of an IL-6-type Hexameric Complex. Journal of Molecular Biology. 254(5). 795–800. 48 indexed citations
17.
Saggio, Isabella, Isabelle Gloaguen, & Ralph Laufer. (1995). Functional phage display of ciliary neurotrophic factor. Gene. 152(1). 35–39. 29 indexed citations
18.
Laufer, Ralph, André Klarsfeld, & Jean‐Pierre Changeux. (1991). Phorbol esters inhibit the activity of the chicken acetylcholine receptor α‐subunit gene promoter. European Journal of Biochemistry. 202(3). 813–818. 22 indexed citations
19.
Laufer, Ralph, et al.. (1991). Pseudopeptide analogs of substance P and leucine enkephalinamide containing the .psi.(methyleneoxy) modification: synthesis and biological activity. Journal of Medicinal Chemistry. 34(8). 2430–2438. 23 indexed citations
20.
Frey, Joseph M., Ralph Laufer, Chaim Gilon, et al.. (1987). Behavioural effects of receptor-specific substance P agonists. Pain. 31(2). 263–276. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keld Fosgerau Breakdown of academic impact, for papers by Laura A. Solt Breakdown of academic impact, for papers by Matthias Engel Breakdown of academic impact, for papers by Yasuyuki Ishii Breakdown of academic impact, for papers by Kentaro Oh‐hashi Breakdown of academic impact, for papers by Xiaorong Zhu Breakdown of academic impact, for papers by Hans‐Gottfried Genieser Breakdown of academic impact, for papers by Michael D. Knierman Breakdown of academic impact, for papers by Ronald D. Sekura Breakdown of academic impact, for papers by Serge Picard
Rankless by CCL
2026